Sort by
Study of Pd–Ag dental alloys: examination of effect of casting porosity on fatigue behavior and microstructural analysis

The goals of this study were to investigate the fatigue limits of two Pd-Ag alloys (Ivoclar Vivadent) with differing mechanical properties and varying proportions of secondary alloying elements, examine the effect of casting porosity on fatigue behavior, and determine the effect of casting size on microstructures and Vickers hardness. The alloys selected were: IPS d.SIGN 59 (59.2Pd-27.9Ag-8.2Sn-2.7In-1.3Zn); and IS 64 (59.9Pd-26.0Ag-7.0Sn-2.8Au-1.8 Ga-1.5In-1.0Pt). Tension test bars, heat-treated to simulate dental porcelain application, were subjected to cyclic loading at 10 Hz, with R-ratio of -1 for amplitudes of compressive and tensile stress. Two replicate specimens were tested at each stress amplitude. Fracture surfaces were examined with a scanning electron microscope (SEM). Sectioned fatigue specimens and additional cast specimens simulating copings for a maxillary central incisor restoration were also examined with the SEM, and Vickers hardness was measured using 1 kg load. Casting porosity was evaluated in sectioned fatigue fracture specimens, using an image analysis program. The fatigue limit (2 × 10(6) loading cycles) of IS 64 was approximately 0.20 of its 0.2% yield strength, while the fatigue limit of d.SIGN 59 was approximately 0.25 of its 0.2% yield strength. These relatively low ratios of fatigue limit to 0.2% yield strength are similar to those found previously for high-palladium dental alloys, and are attributed to their complex microstructures and casting porosity. Complex fatigue fracture surfaces with striations were observed for both alloys. Substantial further decrease in the number of cycles for fatigue failure only occurred when the pore size and volume percentage became excessive. While the heat-treated alloys had equiaxed grains with precipitates, the microstructural homogenization resulting from simulated porcelain firing differed considerably for the coping and fatigue test specimens; the latter specimens had significantly higher values of Vickers hardness.

Relevant
Issues and Design Solutions Associated with Performing MRI Scans on Patients with Active Implantable Medical Devices

Magnetic Resonance Imaging (MRI) has become one of medicine's most important diagnostic tools. However, due to patient safety concerns, MRI is contraindicated by both device and MRI equipment manufacturers for patients with active implanted medical devices (AIMDs). The primary concern is overheating of implanted leadwires due to currents induced from the powerful RF fields of the MRI scanner. In pacemaker patients, heating of myocardial tissue has caused increase in pacemaker capture threshold and in some cases complete loss of capture (inability to pace). Permanent damage to an implantable cardioverter defibrillator and at least one patient death and another with severe burns along the wires of deep brain electrodes have also been reported. The authors, with pacemaker leadwires placed in a "worse case" MRI scan condition, have measured distal tip leadwire temperatures of up to 57 degrees C (more than sufficient to cause tissue damage). Another risk is localized myocardial ablation which could result in changes in the action potential vector during atrial/ventricular contraction. However, in contrast to reports of problems, there have been several recent anecdotal reports of MRI scans being safely performed on non-pacemaker dependent patients under highly controlled conditions. Proper diagnosis, treatment and management of a number of life threatening diseases such as cancer, neurological and brain disorders are made possible by MRI. Accordingly, the physician, with informed patient consent, must sometimes ignore the legal contraindications, weigh the risk factors, and go ahead and perform an MRI on an AIMD patient. This paper quantifies the attendant risks of performing MRI on AIMD patients and discusses means of mitigating certain hazards such as leadwire overheating including the performance a new leadwire distal tip resonant bandstop filter chip (MRI Chip) which presents a high impedance at the MRI pulsed RF frequency.

Relevant
Factors that affect magnetic resonance imaging–induced heating of pacemaker and implantable cardioverter-defibrillator lead wires including certain worst case conditions that could lead to myocardial tissue damage

There are conflicting data regarding the clinical benefits of device-based remote monitoring (RM). We sought to assess the effect of device-based RM on long-term clinical outcomes in recipients of implantable cardioverter-defibrillators (ICDs).We assessed the incidence of adverse cardiac events, overall mortality and device therapy efficacy and safety in a propensity score-matched cohort of patients under RM compared to patients under conventional follow-up. Data on hospitalizations, mortality and cause of death were systematically assessed using a nationwide healthcare platform. The primary outcome was time to a composite outcome of first hospital admission for heart failure or cardiovascular death.Of a total of 923 implantable device recipients, 164 matched patients were identified (84 under RM, 84 under conventional follow-up). The mean follow-up was 44 months (range 1-123). There were no significant differences regarding baseline characteristics in the matched cohorts. Patients under RM had a significantly lower incidence of the primary outcome (hazard ratio [HR] 0.42, confidence interval [CI] 0.20-0.88, p=0.022); there was a non-significant trend towards lower overall mortality (HR 0.53, CI 0.27-1.04, p=0.066). No significant differences between cohorts were found regarding appropriate therapies (RM vs. conventional follow-up, 8.1 vs. 8.2%, p=NS) or inappropriate therapies (6.8 vs. 5.0%, p=NS).In a propensity score-matched cohort of ICD recipients with long-term follow-up, RM was associated with a lower rate of a combined endpoint of hospital admission for heart failure or cardiovascular death.Existem dados contraditórios acerca dos benefícios clínicos da monitorização remota (MR). Os autores procuraram aferir o efeito da MR de dispositivos cardíacos implantáveis em eventos clínicos a longo prazo.Os autores avaliaram a incidência de eventos cardíacos adversos, mortalidade global, e a eficácia e segurança das terapêuticas entregues pelo dispositivo numa amostra de pacientes portadores de cardioversor-desfibrilhador implantável (CDI) após emparelhamento por propensity score, comparando doentes sob MR com doentes em seguimento convencional. Dados relativos a hospitalizações, mortalidade e causa de morte foram sistematicamente avaliados com recurso à Plataforma de Dados de Saúde. A análise primária consistiu no tempo até um evento composto de internamento por insuficiência cardíaca (IC) ou morte cardiovascular.Num total de 923 portadores de dispositivos cardíacos, identificámos 164 pacientes emparelhados (84 sob MR, 84 sob seguimento convencional. O tempo médio de seguimento foi 44 meses (entre 1-123 meses). Não se observaram diferenças significativas nas características basais entre os dois grupos após emparelhamento por propensity score. Doentes sob MR tiveram uma incidência significativamente menor do evento composto de internamento por IC ou morte de causa cardiovascular (hazard ratio [HR] 0,42; intervalo de confiança [IC] 0,20-0,88; p=0,022); houve uma tendência não estatisticamente significativa para uma menor mortalidade global (HR 0,53; IC 0,27-1,04; p=0,066). Não se observaram diferenças entre grupos relativamente a terapêuticas apropriadas (MR versus seguimento convencional; 8,1 versus 8,2%, p=NS) ou terapêuticas inapropriadas (6,8 versus 5,0%, p=NS).Numa amostra emparelhada por propensity score de portadores de CDI, a MR associou-se a uma menor incidência de um evento composto de internamento por IC ou morte cardiovascular a longo prazo.

Relevant